$0.00
BPC-157 | TB-500 is a synthetic dual-peptide formulation integrated into a delayed-release matrix for specialized laboratory applications. This combination is frequently utilized in in-vitro biochemical assays to evaluate co-receptor interactions, peptide stability, and cellular motility under controlled dissolution conditions. This product is strictly designated for research and development purposes and is not intended for human use, diagnostics, therapeutics, or veterinary application.
BPC-157 | TB-500 is a dual-peptide formulation designed for complex structural biology and co-receptor binding assays. BPC-157 provides a highly stable, 15-amino acid sequence featuring significant resistance to enzymatic hydrolysis. TB-500, a synthetic fragment of Thymosin Beta-4, introduces an acetylated N-terminus that enhances its baseline lipophilicity and structural durability. Combined within this specific delivery matrix, the formulation yields an engineered biochemical standard that allows researchers to evaluate dual-receptor signaling in parallel. In laboratory environments, this combinatorial structure is utilized to observe complex protein-protein interactions without rapid peptide degradation. Our preparations achieve purity levels exceeding 98% by HPLC for both sequences, with consistent batch-to-batch reproducibility that we document transparently via Certificates of Analysis, ensuring you have highly reliable materials for your biochemical research.
At our company, we're all about making peptide science approachable and reliable for researchers like you. BPC-157 | TB-500 is a dual-action formulation combining a synthetic pentadecapeptide sequence with a synthetic analog of the peptide Thymosin Beta-4. In laboratory environments, this combination is utilized to leverage the synergistic potential of two distinct structural sequences in isolated cellular assays. By coupling the specific receptor-binding properties of BPC-157 with the actin-sequestering capabilities of TB-500, this blend initiates a multi-tiered signaling cascade for controlled in-vitro observation. This specific research formulation is integrated into a delayed-release matrix, providing a precise delivery mechanism for studying co-receptor interactions in complex biochemical models.
In mechanistic terms, researchers utilize this combination to target complementary cellular pathways in isolated models. While BPC-157 is studied for its influence on the NO-cGMP axis and VEGF upregulation to observe simulated vascularization, TB-500 is evaluated for its interaction with G-actin to regulate cytoskeletal structure, allowing researchers to observe the migration of isolated endothelial cells. Mechanistically, this co-administration provides a robust standard for evaluating complex intracellular signaling and cellular dynamics more comprehensively than single-peptide approaches, specifically observing the modulation of target cytokines in cultured environments—we're happy to walk through the science of this cooperative mechanism, offering straightforward interpretations grounded in the data.
This formulation is provided within specialized capsules designed for simulated dissolution testing and controlled release assays:
In summary, the BPC-157 | TB-500 combination emerges as a robust biochemical tool for evaluating synergistic cellular pathways and motility kinetics in laboratory settings, enabling researchers to observe complex molecular interactions with clarity and control. Its dual role in modulating simulated angiogenesis and cytoskeletal dynamics underscores our quiet enthusiasm for formulations that bridge basic chemistry with rigorous in-vitro application, all while upholding the highest standards of quality. Let's advance your laboratory research together, one measured insight at a time.
For Research Use Only. Not for human use. All products offered are intended strictly for laboratory research purposes only. They are NOT for human or animal consumption, nor are they to be used as drugs, diagnostics, therapeutics, food additives, cosmetics, or household chemicals.
The combinatorial action of BPC-157 and TB-500 makes this formulation particularly robust for supporting complex in-vitro cellular motility assays. In isolated fibroblast and myoblast models, this pairing is utilized to evaluate the interplay between BPC-157-mediated receptor activation and TB-500-driven cellular differentiation, offering a comprehensive standard for observing simulated structural remodeling. Isolated endothelial systems are also frequently evaluated; BPC-157’s influence on VEGF expression is observed in concert with TB-500’s actin-sequestering properties to study endothelial cell migration and capillary tube formation in cultured environments. We appreciate the nuance in these co-dependent pathways and are here to provide insights into how these peptides interact in targeted laboratory assays, keeping things logical and approachable.
For optimal stability, store BPC-157 | TB-500 capsules in a cool, dry environment, preferably at 4°C to -20°C, ensuring the container is tightly sealed to shield the peptides from humidity and photodegradation. If extracting contents for solution-based in-vitro assays, both peptides are highly water-soluble; reconstitute in sterile laboratory buffers or standard cell culture media to achieve desired concentrations, employing gentle swirling to dissolve without shearing the peptide chains. Avoid repeated freeze-thaw cycles of reconstituted solutions, as this can degrade the structural integrity; while the capsule offers robust physical protection, the solvated peptides remain sensitive. Backed by our combined stability validations, these steps help maintain structural integrity prior to experimental deployment—reach out if you have questions regarding handling or storage.
By clicking "I AGREE" and entering this website, you acknowledge and certify under penalty of perjury that you are at least 18 years of age.
